Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q3KP22

Entry ID Method Resolution Chain Position Source
6GNX X-ray 290 A A/C 1-49 PDB
6GNY X-ray 185 A A/C 1-49 PDB
6J08 X-ray 290 A A/B/C 2-49 PDB
AF-Q3KP22-F1 Predicted AlphaFoldDB

135 variants for Q3KP22

Variant ID(s) Position Change Description Diseaes Association Provenance
CA223901184
rs866513707
3 L>S No ClinGen
Ensembl
rs775733031
CA6087559
5 P>L No ClinGen
ExAC
gnomAD
CA381182893
rs1342766340
7 T>A No ClinGen
gnomAD
rs1471756429
CA6087556
8 Y>C No ClinGen
TOPMed
CA6087558
rs769971920
8 Y>H No ClinGen
ExAC
gnomAD
rs781719660
CA6087554
9 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs746400819
CA6087555
9 P>T No ClinGen
ExAC
gnomAD
rs747416147
CA6087552
10 F>L No ClinGen
ExAC
gnomAD
CA381182771
rs1306255262
12 E>D No ClinGen
gnomAD
rs778045629
CA6087551
12 E>G No ClinGen
ExAC
gnomAD
rs200290554
CA6087550
13 T>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs747753223
CA6087548
15 F>V No ClinGen
ExAC
rs548422925
CA6087547
16 L>F No ClinGen
1000Genomes
ExAC
gnomAD
CA381182639
rs753774551
17 H>P No ClinGen
ExAC
TOPMed
gnomAD
CA6087545
rs753774551
17 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs867650230
CA223901146
18 A>S No ClinGen
gnomAD
CA381182616
rs867650230
18 A>T No ClinGen
gnomAD
CA6087543
rs755933994
19 G>E No ClinGen
ExAC
gnomAD
rs750259177
CA6087542
20 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1405846084
CA381182523
21 N>S No ClinGen
gnomAD
CA381182449
rs1483057074
23 Y>C No ClinGen
gnomAD
CA6087541
rs368431514
24 K>E No ClinGen
ESP
ExAC
gnomAD
CA6087540
rs529072438
24 K>R No ClinGen
1000Genomes
ExAC
gnomAD
CA6087539
rs775822980
25 F>L No ClinGen
ExAC
gnomAD
CA6087538
rs765479119
27 I>V No ClinGen
ExAC
gnomAD
rs1350212780
CA381182270
29 Y>* No ClinGen
gnomAD
CA381182265
rs1403939432
30 G>R No ClinGen
TOPMed
CA223901122
rs200188712
31 K>E No ClinGen
Ensembl
CA6087535
rs767657443
31 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA6087534
rs747435219
32 S>T No ClinGen
ExAC
gnomAD
rs773591860
CA6087533
33 I>V No ClinGen
ExAC
gnomAD
CA381179558
rs1432025788
35 G>R No ClinGen
TOPMed
rs569704739
CA6087511
36 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs569704739
CA6087510
36 E>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs1414452146
CA381179499
37 E>D No ClinGen
gnomAD
rs1300462997
CA381179510
37 E>G No ClinGen
TOPMed
rs143048018
CA6087508
38 I>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA381179490
rs1185820287
38 I>V No ClinGen
gnomAD
rs1314669096
CA381179453
39 E>K No ClinGen
gnomAD
rs1249641714
CA381179368
42 E>K No ClinGen
gnomAD
CA6087507
rs549528920
47 E>* No ClinGen
1000Genomes
ExAC
gnomAD
rs745867027
CA6087506
47 E>D No ClinGen
ExAC
gnomAD
CA6087505
rs781260955
48 L>P No ClinGen
ExAC
TOPMed
gnomAD
CA381179188
rs1265002004
48 L>V No ClinGen
gnomAD
rs751405480
CA6087503
49 E>Q No ClinGen
ExAC
gnomAD
rs765009614
CA6087369
52 V>G No ClinGen
ExAC
TOPMed
gnomAD
rs752600860
CA6087370
52 V>I No ClinGen
ExAC
gnomAD
rs141674274
CA6087368
57 V>I No ClinGen
ESP
ExAC
gnomAD
CA6087367
rs376267986
58 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372651737
CA6087364
61 M>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372651737
CA6087365
61 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1486256078
CA381210501
62 R>G No ClinGen
gnomAD
rs768821510
CA223934041
64 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs768821510
CA6087363
64 R>G No ClinGen
ExAC
gnomAD
CA6087362
rs749874119
64 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA381210437
rs1477686700
66 H>Q No ClinGen
TOPMed
rs776048754
CA6087361
67 M>V No ClinGen
ExAC
gnomAD
rs145232114
CA381210405
68 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1340432116
CA381210396
69 E>G No ClinGen
gnomAD
rs140240334
CA6087359
69 E>K No ClinGen
ESP
ExAC
gnomAD
rs1409979704
CA381210379
70 P>L No ClinGen
TOPMed
CA381210366
rs1382415214
71 S>R No ClinGen
gnomAD
rs1565125291
CA381210357
72 S>F No ClinGen
Ensembl
CA381210347
rs149450150
73 P>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA6087356
rs149450150
73 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA381210330
rs1437902477
74 S>R No ClinGen
TOPMed
gnomAD
CA6087355
rs780767889
75 R>K No ClinGen
ExAC
TOPMed
gnomAD
CA223933964
rs956655937
78 L>R No ClinGen
TOPMed
rs1429337579
CA381210261
80 R>M No ClinGen
gnomAD
CA381210230
rs1183274722
81 A>T No ClinGen
gnomAD
CA381210216
rs1307565277
83 I>V No ClinGen
gnomAD
rs1565124043
CA381210202
85 T>S No ClinGen
Ensembl
CA381210184
rs1395276768
88 Q>K No ClinGen
gnomAD
CA223933216
rs1023360119
95 P>A No ClinGen
TOPMed
gnomAD
CA381210131
rs1023360119
95 P>S No ClinGen
TOPMed
gnomAD
CA381210121
rs1471072303
97 V>M No ClinGen
gnomAD
rs1223598126
CA381210102
99 T>I No ClinGen
TOPMed
CA6087330
rs200374744
108 Q>P No ClinGen
1000Genomes
ExAC
gnomAD
rs763220707
CA6087329
109 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs763220707
CA6087328
109 Q>K No ClinGen
ExAC
TOPMed
gnomAD
rs992872615
CA223930523
109 Q>R No ClinGen
TOPMed
gnomAD
rs1159699213
CA381209212
110 G>V No ClinGen
TOPMed
gnomAD
rs1470924483
CA381209193
111 L>F No ClinGen
TOPMed
rs1175139223
CA381209187
112 Q>* No ClinGen
TOPMed
CA381209163
rs1457829473
113 E>D No ClinGen
gnomAD
rs1367152047
CA381209139
115 L>V No ClinGen
gnomAD
rs752853902
CA6087327
117 S>C No ClinGen
ExAC
gnomAD
CA6087326
rs765201427
118 D>Y No ClinGen
ExAC
gnomAD
CA381209085
rs1288760353
119 I>V No ClinGen
TOPMed
gnomAD
CA6087325
rs138728143
120 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1448277583
CA381209049
121 D>A No ClinGen
gnomAD
CA381208992
rs1209238969
125 Q>* No ClinGen
gnomAD
rs1031687633
CA223930504
125 Q>P No ClinGen
TOPMed
rs1565117403
CA381208927
126 D>A No ClinGen
Ensembl
CA6087323
rs771350941
126 D>N No ClinGen
ExAC
gnomAD
CA381208896
rs1341738310
128 E>A No ClinGen
gnomAD
CA381208889
rs758734857
128 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA223930137
rs1037819430
129 W>R No ClinGen
TOPMed
gnomAD
CA223930132
rs369863006
130 G>E No ClinGen
ESP
TOPMed
gnomAD
CA381208874
rs1343689264
130 G>R No ClinGen
gnomAD
CA223930127
rs558618357
131 H>P No ClinGen
TOPMed
gnomAD
rs1370405763
CA381208844
132 S>G No ClinGen
gnomAD
CA6087309
rs765416026
135 G>E No ClinGen
ExAC
gnomAD
CA381208788
rs1171595125
COSM1197937
136 R>Q Variant assessed as Somatic; 4.624e-05 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs766883280
CA6087306
140 P>S No ClinGen
ExAC
gnomAD
rs149077208
CA6087303
145 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1057442855
CA381208643
146 P>L No ClinGen
Ensembl
rs1057442855
CA223930104
146 P>R No ClinGen
Ensembl
CA6087302
rs761571890
146 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1321577560
CA381208612
148 P>L No ClinGen
gnomAD
CA381208616
rs1200073404
148 P>S No ClinGen
gnomAD
rs1285267701
CA381208578
151 R>* No ClinGen
TOPMed
gnomAD
rs1285267701
CA381208579
151 R>G No ClinGen
TOPMed
gnomAD
rs768291200
CA6087300
151 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA381208562
rs1350427284
152 A>V No ClinGen
TOPMed
gnomAD
CA381208554
rs1428653153
153 A>G No ClinGen
TOPMed
CA381208548
rs1173913572
154 T>A No ClinGen
TOPMed
rs550355388
CA6087298
155 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA381208512
rs1302186657
158 G>E No ClinGen
TOPMed
rs745770673
CA6087296
159 F>V No ClinGen
ExAC
gnomAD
CA381208489
rs1293113274
161 S>N No ClinGen
TOPMed
rs1394233938
CA381208466
163 L>F No ClinGen
TOPMed
rs1311694873
CA381208461
164 F>L No ClinGen
TOPMed
CA6087281
rs762628309
165 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA381208451
rs762628309
165 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs531700220
CA6087279
167 R>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA223929704
rs531700220
167 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA223929702
rs948268193
167 R>Q No ClinGen
TOPMed
gnomAD
CA381208434
rs1590685958
168 Y>F No ClinGen
Ensembl
rs1240415257
CA381208396
171 R>G No ClinGen
TOPMed
gnomAD
CA381208363
rs1590685928
173 S>T No ClinGen
Ensembl
CA6087278
rs187236670
174 S>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA223929695
rs992257825
174 S>I No ClinGen
TOPMed
CA381208336
rs1291613257
175 H>R No ClinGen
TOPMed
gnomAD
CA381208310
rs1315370839
177 S>S No ClinGen
TOPMed
gnomAD

No associated diseases with Q3KP22

No regional properties for Q3KP22

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q3KP22

Functions

Description
EC Number
Subcellular Localization
  • Nucleus inner membrane ; Single-pass membrane protein
  • Chromosome, telomere
  • In leptotene spermatocytes, localizes to telomeres that localize to the nucleus inner membrane
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
chromosome, telomeric region The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres).
integral component of nuclear inner membrane The component of the nuclear inner membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

1 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

3 GO annotations of biological process

Name Definition
homologous chromosome pairing at meiosis The meiotic cell cycle process where side by side pairing and physical juxtaposition of homologous chromosomes is created during meiotic prophase. Homologous chromosome pairing begins when the chromosome arms begin to pair from the clustered telomeres and ends when synaptonemal complex or linear element assembly is complete.
meiotic attachment of telomere to nuclear envelope The meiotic cell cycle process in which physical connections are formed between telomeric heterochromatin and the nuclear envelope, facilitating bouquet formation.
meiotic telomere clustering The cell cycle process in which the dynamic reorganization of telomeres occurs in early meiotic prophase, during which meiotic chromosome ends are gathered in a bouquet arrangement at the inner surface of the nuclear envelope proximal to the spindle pole body. This plays an important role in progression through meiosis and precedes synapsis.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSLKPFTYPF PETRFLHAGP NVYKFKIRYG KSIRGEEIEN KEVITQELEV PVEKKAVGAV
70 80 90 100 110 120
MRKRKHMDEP SSPSRPGLDR AKIGTSSQGP SKKKPPVETR RNRERKTQQG LQETLASDIT
130 140 150 160 170
DVQKQDSEWG HSLPGRIVPP LQHNSPPPKE RAATGFFGFL SSLFPFRYFF RKSSHS